
Hearing loss affects approximately 1.5 billion people worldwide, making it the most prevalent sensory disability. Hearing aids and cochlear implants are established interventions; drug-based approaches targeting hair cell regeneration are advancing in clinical trials. Noise exposure prevention, newborn hearing screening, and reducing the global treatment gap are central public health priorities.